Nashua, NH
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)Nashua Regional Cancer Center Inc, founded in 1991, is a community nonprofit in the Diseases & Disorders sector that reported $6.2M in total revenue in fiscal year 2025. Revenue grew 15% year-over-year, indicating healthy expansion. Expenses of $5.4M left a modest 14% surplus.
The mission of NRCC is to improve the quality of life for individuals impacted by cancer, by providing state of the art comprehensive radiation therapy services for individuals residing in the greater Nashua area.A collaborative effort of Mary Hitchcock Memorial Hospital, St. Joseph Hospital, and Southern New Hampshire Medical Center, NRCC represents a multi-hospital approach to the provision of radiation treatment. Established in 1992 as a free-standing outpatient facility, this American Society for Radiation Oncology (ASTRO) program of excellence, under the medical/clinical direction of Radiation Oncology Associates, PA, has served the community of greater Nashua in its mission to provide state of the art radiation therapy treatment.
The Nashua Regional Cancer Center provided services to 610 outpatients. NRCC defines its service area both geographically as well as diagnostically. NRCC was created as a vehicle to provide radiation...
The Nashua Regional Cancer Center provided services to 610 outpatients. NRCC defines its service area both geographically as well as diagnostically. NRCC was created as a vehicle to provide radiation treatment for the service areas of Southern NH Medical Center and St. Joseph Hospital, and Mary Hitchcock Memorial Hospital in NH. Their combined market share (NRCC's market share) encompasses a primary area of nine towns, (Amherst, Brookline, Hollis, Hudson, Litchfield, Merrimack, Milford, Nashua, and Wilton) and a secondary area of nine towns as well (Dunstable, MA, Greenville, Mason, Londonderry, Lyndeborough, Mont Vernon, Pelham, Pepperell, MA, Windham). Services provided by NRCC are limited to support, education, information, and treatment related to cancer and non-malignant diagnosis as outline by accreditation society American Society for Radiation Oncology. NRCC invested $166,121 for Health Professions Education, $680 to provide RN assessments, $2,877 to provide medical interpretation, and $76,818 to provide social workers. NRCC also provided $61,111.16 of free and discounted health care services. Medicare and Medicaid adjusted reimbursement discounts totaled $4,335,816.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2025 | 2024 | Change | |
|---|---|---|---|
| Revenue | $6,220,505 | $5,428,552 | +0.1% |
| Expenses | $5,350,447 | $4,873,334 | +0.1% |
| Net Income | $870,058 | $555,218 | +0.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| John Jurczyk | Chairman | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Kenneth Matsis | Treasurer | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Michelle Proulx | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Deborah Scribner | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Jon Vore | Board Member | 1.00 |
Director
|
$0 | $0 | $0 |
| Andrew DesRosiers | Executive Director | 40.00 |
Officer
|
$178,629 | $38,736 | $217,365 |
| Jennifer Tucker | Chief Physicist | 32.00 |
Highest
|
$294,983 | $10,820 | $305,803 |
| Charles Mangano | Chief RT | 40.00 |
Highest
|
$175,572 | $39,550 | $215,122 |
| Li Xiong | Physicist | 24.00 |
Highest
|
$197,787 | $10,724 | $208,511 |
| Scott Cail | Dosimetrist | 40.00 |
Highest
|
$165,977 | $30,665 | $196,642 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2025 | $6,220,505 | $5,350,447 | $6,990,832 | $870,058 |
| 2024 | $5,428,552 | $4,873,334 | $5,882,796 | $555,218 |
| 2023 | $5,254,325 | $4,847,769 | $5,326,556 | $406,556 |
| 2022 | $5,891,882 | $4,928,001 | $4,921,317 | $963,881 |
| 2021 | $5,524,984 | $5,023,258 | $5,236,780 | $501,726 |
| 2020 | $5,208,710 | $4,688,878 | $7,061,482 | $519,832 |
| 2019 | $6,047,855 | $4,492,121 | $6,195,859 | $1,555,734 |
| 2018 | $5,493,453 | $4,543,841 | $6,443,077 | $949,612 |
Compare Nashua Regional Cancer Center Inc with other nonprofits in New Hampshire and across the country.